Codexis, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDXS research report →
Companywww.codexis.com
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening.
- CEO
- Alison Moore
- IPO
- 2010
- Employees
- 188
- HQ
- Redwood City, CA, US
Price Chart
Valuation
- Market Cap
- $234.51M
- P/E
- -7.32
- P/S
- 3.00
- P/B
- 5.42
- EV/EBITDA
- -16.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 83.94%
- Op Margin
- -33.15%
- Net Margin
- -40.96%
- ROE
- -68.09%
- ROIC
- -21.97%
Growth & Income
- Revenue
- $70.39M · 18.61%
- Net Income
- $-43,974,000 · 32.63%
- EPS
- $-0.50 · 43.82%
- Op Income
- $-38,332,000
- FCF YoY
- 55.60%
Performance & Tape
- 52W High
- $3.87
- 52W Low
- $0.96
- 50D MA
- $2.18
- 200D MA
- $2.05
- Beta
- 2.53
- Avg Volume
- 2.37M
Get TickerSpark's AI analysis on CDXS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 23, 26 | Lutz Stefan | other | 316,100 |
| Feb 24, 26 | Lutz Stefan | sell | 5,862 |
| Feb 23, 26 | MOORE ALISON | other | 993,000 |
| Feb 23, 26 | Erbez Georgia | other | 316,100 |
| Feb 6, 26 | Lutz Stefan | sell | 2,492 |
| Feb 6, 26 | Erbez Georgia | sell | 3,826 |
| Feb 6, 26 | MOORE ALISON | sell | 3,826 |
| Jan 7, 26 | Lutz Stefan | sell | 4,685 |
| Nov 26, 25 | Opaleye Management Inc. | sell | 148,318 |
| Nov 7, 25 | Opaleye Management Inc. | sell | 296,682 |
Our CDXS Coverage
We haven't published any research on CDXS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CDXS Report →